We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

This study has been terminated.
(Study no longer feasible as quantitative assessment of fFN can only be performed at one laboratory.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01279369
First Posted: January 19, 2011
Last Update Posted: January 12, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Wendy Kinzler, MD, Winthrop University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)